1 / 1

Long-term Outcomes of Tegafur/Uracil and Other Therapies in Cancer Treatment

This analysis presents multiple case studies exploring the long-term effects of various cancer therapies, including tegafur/uracil, 5-FU, and CPT-11. Cases include patients treated with tegafur/uracil for 8 months, 2 years, and other regimens including 5-FU for 3 years and peptide vaccine therapy. The outcomes highlight the efficacy and tolerance of these treatments over extended periods, offering valuable insights into management strategies for oncology.

lluvia
Télécharger la présentation

Long-term Outcomes of Tegafur/Uracil and Other Therapies in Cancer Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. tegafur/uracil Case 1 for 8 months Case 3 tegafur/uracil for 2 years Case 5 5-FU for 3 years tegafur/uracil Case 6 CPT-11 for 2 months LV Case 7 5-FU for 2 months operation CPT-11 ＋ 5‘-DFUR Case 9 for 1 year Peptide vaccine therapy

More Related